Latest Thesis
Medtronic: the device giant has scale, but the proof is durable growth after reinvestment
Medtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.
Financials and workspace tools are for paid members.
Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.
Recent Reports
Compact report index for this company.
ReportTypeUpdatedReadActions
Medtronic: the device giant has scale, but the proof is durable growth after reinvestmentMedtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.NYSEMay 20, 2026Research reportReadSlides